A case-control study: Association between serum neuregulin 4 level and non-alcoholic fatty liver disease

Metabolism: Clinical and Experimental

Volumn 64, Issue 12, 2015, Pages 1667-1673

  Dai, Yi Ning ^a   Zhu, Jin Zhou ^a   Fang, Zhi Yun ^a   Zhao, De Jian ^a   Wan, Xing Yong ^a   Zhu, Hua Tuo ^a   Yu, Chao Hui ^a   Li, You Ming ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Neuregulin 4; Non alcoholic fatty liver disease; Obesity

Indexed keywords

GLUCOSE; NEU DIFFERENTIATION FACTOR; NEUREGULIN 4; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; NEUREGULIN-4;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BIOCHEMICAL ANALYSIS; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; AGED; ANALYSIS; BLOOD; BODY MASS; BROWN ADIPOSE TISSUE; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PHYSIOLOGY; STATISTICAL MODEL;

ADIPOSE TISSUE, BROWN; ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEUREGULINS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY;

EID: 84947934602     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2015.08.013     Document Type: Article

References (26)

1. N. Sattar, E. Forrest, and D. Preiss Non-alcoholic fatty liver disease BMJ 349 2014 g4596 10.1136/bmj.g4596
2. E. Bugianesi, N. Leone, G. Marchesini, F. Brunello, P. Carucci, and et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology 123 2002 134 140
3. N. Mendez-Sanchez, M. Arrese, D. Zamora-Valdes, and M. Uribe Current concepts in the pathogenesis of nonalcoholic fatty liver disease Liver Int 27 2007 423 433
4. M. Bluher, and C.S. Mantzoros From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century Metabolism 64 2015 131 145
5. S.A. Polyzos, and C.S. Mantzoros Leptin in health and disease: facts and expectations at its twentieth anniversary Metabolism 64 2015 5 12
6. S.A. Polyzos, J. Kountouras, and C.S. Mantzoros Leptin in nonalcoholic fatty liver disease: a narrative review Metabolism 64 2015 60 78
7. S.A. Polyzos, J. Kountouras, A.D. Anastasilakis, E.V. Geladari, and C.S. Mantzoros Irisin in patients with nonalcoholic fatty liver disease Metabolism 63 2014 207 217
8. E.S. Choi, M.K. Kim, M.K. Song, J.M. Kim, E.S. Kim, and W.J. Chung Association between serum irisin levels and non-alcoholic fatty liver disease in health screen examinees PLoS One 9 2014 e110680 10.1371/journal.pone.0110680
9. S.A. Polyzos, K.A. Toulis, D.G. Goulis, C. Zavos, and J. Kountouras Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis Metabolism 60 2011 313 326
10. A. Pfeifer NRG4: an endocrine link between brown adipose tissue and liver Cell Metab 21 2015 13 14
11. M. Rosell, M. Kaforou, A. Frontini, A. Okolo, Y.W. Chan, E. Nikolopoulou, and et al. Brown and white adipose tissues: intrinsic differences in gene expression and response to cold exposure in mice Am J Physiol Endocrinol Metab 306 2014 E945 E964
12. G.X. Wang, X.Y. Zhao, Z.X. Meng, M. Kern, A. Dietrich, Z. Chen, and et al. The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis Nat Med 20 2014 1436 1443
13. J.G. Fan, J.D. Jia, Y.M. Li, B.Y. Wang, L.G. Lu, J.P. Shi, and et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010 (published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166) J Dig Dis 12 2011 38 44
14. S.H. Saverymuttu, A.E. Joseph, and J.D. Maxwell Ultrasound scanning in the detection of hepatic fibrosis and steatosis Br Med J (Clin Res Ed) 292 1986 13 15
15. M. Acikel, S. Sunay, M. Koplay, F. Gundogdu, S. Karakelleoglu, and et al. Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography Anadolu Kardiyol Derg 9 2009 273 279
16. J. Nedergaard, T. Bengtsson, and B. Cannon Unexpected evidence for active brown adipose tissue in adult humans Am J Physiol Endocrinol Metab 293 2007 E444 E452
17. W.D. van Marken Lichtenbelt, J.W. Vanhommerig, N.M. Smulders, J.M. Drossaerts, G.J. Kemerink, N.D. Bouvy, and et al. Cold-activated brown adipose tissue in healthy men N Engl J Med 360 2009 1500 1508
18. A.M. Cypess, S. Lehman, G. Williams, I. Tal, D. Rodman, A.B. Goldfine, and et al. Identification and importance of brown adipose tissue in adult humans N Engl J Med 360 2009 1509 1517
19. K.A. Virtanen, M.E. Lidell, J. Orava, M. Heglind, R. Westergren, T. Niemi, and et al. Functional brown adipose tissue in healthy adults N Engl J Med 360 2009 1518 1525
20. G.X. Wang, X.Y. Zhao, and J.D. Lin The brown fat secretome: metabolic functions beyond thermogenesis Trends Endocrinol Metab 26 2015 231 237
21. J. Nedergaard, and B. Cannon The changed metabolic world with human brown adipose tissue: therapeutic visions Cell Metab 11 2010 268 272
22. S. Enerback Human brown adipose tissue Cell Metab 11 2010 248 252
23. M.R. Schneider, and E. Wolf The epidermal growth factor receptor ligands at a glance J Cell Physiol 218 2009 460 466
24. S. Ballestri, A. Lonardo, D. Romagnoli, L. Carulli, L. Losi, C.P. Day, and et al. Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD Liver Int 32 2012 1242 1252
25. M. Graif, M. Yanuka, M. Baraz, A. Blank, M. Moshkovitz, A. Kessler, and et al. Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease Invest Radiol 35 2000 319 324
26. S. Ballestri, D. Romagnoli, F. Nascimbeni, G. Francica, A. Lonardo, and et al. Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications Expert Rev Gastroenterol Hepatol 9 2015 603 627